Artisan Partners
ICPT

Artisan Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Artisan Partners’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-55,012
Closed -$15.5M – 401
2015
Q1 		$15.5M Buy
55,012
+24,932
+83% +$5.4M 0.03% 255
2014
Q4 		$4.69M Buy
30,080
+30
+0.1% +$5.54K 0.01% 341
2014
Q3 		$7.11M Buy
+30,050
New +$7.66M 0.01% 338
2014
Q2 		– Sell
-175,733
Closed -$58M – 376
2014
Q1 		$58M Buy
+175,733
New +$59.3M 0.1% 185

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners's ICPT Position: Q2 2015 in Review

Artisan Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 55,012 shares — an estimated $15.5M sold.

Artisan Partners first reported a position in ICPT in Q1 2014 and held it in 4 quarters. The position peaked at $58M in Q1 2014. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • Artisan Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Artisan Partners sold 55,012 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $15.5M.
  • Artisan Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
  • Artisan Partners's Intercept Pharmaceuticals, Inc. position peaked at $58M in Q1 2014.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on Artisan Partners's 13F filing for Q2 2015, filed 11 Aug 2015.